Jinkai Wan

Shanghai Key Laboratory Of Medical Epigenetics, Key Laboratory Of Carcinogenesis And Cancer Invasion
Zhongshan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

KDM7B-mediated demethylation of RNF113A regulates small cell lung cancer sensitivity to alkylation damage.

KDM7B-mediated demethylation of RNF113A regulates small cell lung cancer sensitivity to alkylation damage.

Journal: bioRxiv : the preprint server for biology

Published: January 09, 2026

MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response.

MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 02, 2025

Correction: DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming.

Correction: DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming.

Journal: Cancer discovery

Published: February 14, 2025

Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets.

Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets.

Journal: Cancer discovery

Published: September 26, 2024

SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinoma.

SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinoma.

Journal: Cell research

Published: June 19, 2024

DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming.

DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming.

Journal: Cancer discovery

Published: May 06, 2024

The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation.

The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation.

Journal: Nature communications

Published: April 22, 2023

PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti-PD-1 Immunotherapy.

PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti-PD-1 Immunotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 24, 2023

A Novel Quantitative Electrocardiography Strategy Reveals the Electroinhibitory Effect of Tamoxifen on the Mouse Heart.

A Novel Quantitative Electrocardiography Strategy Reveals the Electroinhibitory Effect of Tamoxifen on the Mouse Heart.

Journal: Journal of cardiovascular translational research

Published: January 28, 2023

The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2.

The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2.

Journal: Signal transduction and targeted therapy

Published: October 04, 2020

Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.

Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.

Journal: Cell reports

Published: May 27, 2020

Ribosome 18S m6A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth.

Ribosome 18S m6A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth.

Journal: Cell reports

Published: April 21, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026